METVIX PHOTODYNAMIC
THERAPY

Metvix Photodynamic Therapy is a non-invasive treatment for actinic keratoses and superficial basal cell carcinomas. The process involves the application of the Metvix, or methyl aminolevulinate cream, to the treatment area. The cream is left on the skin for 2.5 – 3 hours, at which time a red light is applied to activate the Metvix cream. The activated cream will only react with and treat the targeted skin cells while the surrounding healthy skin cells receive minimal to no reaction from the treatment. The number of treatments depends on the severity of the condition; however, an average of two treatments is typical, spaced 1-6 months apart. Results can last for several years depending on after-care and the initial condition of the skin. Additional maintenance treatments are required in some cases.